Betamethasone (CAS 378-44-9) – Anti-inflammatory API

Betamethasone (CAS 378-44-9) is a high-potency glucocorticoid anti-inflammatory API with strong anti-inflammatory, anti-allergic, and immunosuppressive properties. Its molecular mechanism targets the inhibition of inflammatory mediator release and immune cell activation, providing rapid relief from inflammatory symptoms. Manufactured under GMP-certified processes, it ensures consistent purity, bioactivity, and stability, meeting the strictest global pharmaceutical standards.

This premium API is a critical raw material for pharmaceutical manufacturers developing topical and systemic medications. It is widely applied in formulating drugs for dermatological conditions, rheumatoid arthritis, asthma, and other inflammatory disorders. With proven clinical efficacy and targeted action, it caters to the demand for effective anti-inflammatory treatments. For pharmaceutical enterprises and research institutions, it offers a reliable, high-performance solution to advance inflammatory disease therapies.